View in EDS HTML Full Text PDF Full Text

Identifying a Common Autoimmune Gene Core as a Tool for Verifying Biological Significance and Applicability of Polygenic Risk Scores.

Saved in:
Bibliographic Details
Title: Identifying a Common Autoimmune Gene Core as a Tool for Verifying Biological Significance and Applicability of Polygenic Risk Scores.
Authors: Shchekina VS; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow 125315, Russia.; Moscow Center for Advanced Studies, Kulakova Street 20, Moscow 123592, Russia., Batashkov NA; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow 125315, Russia.; Moscow Center for Advanced Studies, Kulakova Street 20, Moscow 123592, Russia., Maznina AA; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow 125315, Russia., Krupinova JA; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow 125315, Russia.; Moscow Center for Advanced Studies, Kulakova Street 20, Moscow 123592, Russia.; Moscow Clinical Scientific Center N.A. A.S. Loginov, Novogireevskaya Street, 1, 1, Moscow 111123, Russia., Bogdanov VP; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow 125315, Russia.; Moscow Center for Advanced Studies, Kulakova Street 20, Moscow 123592, Russia., Korobeinikova AV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 119121, Russia., Tychinin DI; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 119121, Russia., Glushkova OV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 119121, Russia., Petriaikina ES; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 119121, Russia., Svetlichnyy DV; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 119121, Russia., Woroncow M; Moscow Center for Advanced Studies, Kulakova Street 20, Moscow 123592, Russia., Yudin VS; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 119121, Russia., Keskinov AA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 119121, Russia., Yudin SM; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 119121, Russia., Skvortsova VI; The Federal Medical Biological Agency (FMBA of Russia), Moscow 123182, Russia., Tabakov DV; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow 125315, Russia.; Moscow Center for Advanced Studies, Kulakova Street 20, Moscow 123592, Russia., Deviatkin AA; Federal State Budgetary Institution «Centre for Strategic Planning and Management of Biomedical Health Risks» of the Federal Medical and Biological Agency (Centre for Strategic Planning, of the Federal Medical and Biological Agency), Moscow 119121, Russia., Volchkov PY; Federal State Budgetary Scientific Institution 'Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies', Moscow 125315, Russia.; Moscow Center for Advanced Studies, Kulakova Street 20, Moscow 123592, Russia.; Moscow Clinical Scientific Center N.A. A.S. Loginov, Novogireevskaya Street, 1, 1, Moscow 111123, Russia.
Source: International journal of molecular sciences [Int J Mol Sci] 2026 Jan 05; Vol. 27 (1). Date of Electronic Publication: 2026 Jan 05.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1422-0067
DOI:10.3390/ijms27010543